EQS-News

Drägerwerk AG & Co. KGaA: Dräger makes sustainability and quality an Executive Board responsibility

EQS-News: Drägerwerk AG & Co. KGaA / Key word(s): Personnel/Sustainability Drägerwerk AG & Co. KGaA: Dräger makes sustainability and quality an Executive Board responsibility 08.05.2024 / 16:45 CET/CEST The issuer is solely responsible for the content of this announcement. Dräger makes sustainability and quality an Executive Board responsibility

Stefanie Hirsch will be appointed to the Executive Board as of July 1, 2024

Dräger is creating a new, additional Executive Board position for sustainability and quality. At its meeting today, the Supervisory Board of Drägerwerk Verwaltungs AG decided to appoint Stefanie Hirsch to the Executive Board as Chief Sustainability and Quality Officer as of July 1, 2024. 

"Sustainability has always been deeply rooted in Dräger's corporate culture and is becoming increasingly important for the future. It is a cross-cutting topic and affects all processes and areas of our company. The same applies to quality, one of our four strengths and a cornerstone of our company. I am delighted to have Stefanie Hirsch as an experienced and committed colleague on the Executive Board." - Stefan Dräger, CEO of Drägerwerk Verwaltungs AG.

Stefanie Hirsch was born in Worms, Germany in 1975 and studied biotechnology at Mannheim University of Applied Sciences. She began her professional career at Abbott Diagnostics in the Research & Development department. This was followed by various management positions in the areas of Operations, Quality and Regulatory Affairs, including abroad. She has also worked at Ortho-Clinical Diagnostics, a global provider of products and services for transfusion services and clinical laboratories, where she led the quality management and regulatory affairs teams in the company's international sales & service offices in the EMEA and Asia regions.

Hirsch has been with Dräger since 2018 and is Head of Quality and Regulatory Affairs in Medical Technology. She has also been Head of Corporate Quality & Regulatory Affairs, including Global Environmental Health and Safety Management, since 2020.

Image material:

Photo: Stefanie Hirsch will be appointed to the Executive Board of Drägerwerk Verwaltungs AG as of July 1, 2024.  Drägerwerk AG & Co. KGaA

Dräger. Technology for Life
Dräger is an international leader in the fields of medical and safety technology. Our products protect, support, and save lives. Founded in 1889, Dräger generated revenues of around € 3,4 billion in 2023. The Dräger Group is currently present in over 190 countries and has more than 16,000 employees worldwide. For more information, visit www.draeger.com.

 

---

08.05.2024 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com

---

Language:	English
Company:	Drägerwerk AG & Co. KGaA
	Moislinger Allee 53-55
	23558 Lübeck
	Germany
Phone:	[phone]
Fax:	[phone]
E-mail:	[e-mail]
Internet:	www.draeger.com
ISIN:	DE0005550602, DE 000 555 063 6, DE 000 555 071 9
WKN:	555060, 555063 Vorzüge, 555071 Genussschein D
Indices:	SDAX
Listed:	Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Stuttgart, Tradegate Exchange
EQS News ID:	1899015

End of News	EQS News Service

1899015  08.05.2024 CET/CEST

Draegerwerk

-0,70 %

+0,92 %

-3,24 %

+5,00 %

+1,13 %

-33,08 %

-6,71 %

-34,89 %

+1.209,09 %

ISIN:DE0005550636WKN:555063

• Intraday
• 5 Tage
• 1 Monat
• 3M
• 1 Jahr
• 3J
• 5J
• 10J
• Max